EN
HI
Piramal Pharma Chart
Piramal Pharma Share Key Metrics
Volume
37.43 L
Market Cap
18390.15 CR
LTQ@LTP
65@138.35
ATP
138.26
Var Margin
17.91 %
Circuit Range
122.15-149.29
Delivery %
34.17 %
Value
51.74 CR
ASM/GSM
No
Market Lot
1
Summary
At 20 Mar, 2026 | 15:53, Piramal Pharma share price stands at ₹138.35, showing a 2.63% 1.94 for the day. The stock’s intraday movement has stayed between ₹136.79 and ₹139.71, while on a 52-week basis it has fluctuated from ₹134.60 to ₹240.95.
In terms of trading activity, Piramal Pharma has recorded a volume of 3742561 shares, with a market capitalisation of ₹1329248130. The stock’s Average Traded Price (ATP) stands at ₹13826, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 65,13835. The stock operates within a circuit range of ₹122.15-149.29, with a Value of ₹51.74 CR. The Delivery Percentage for the day is 34.17%. Additionally, Piramal Pharma currently falls under the No framework, and trades with a market lot size of 1.
Piramal Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
2.28
Div. Yield
0.1
Sector P/E
59.61
Sector P/B
2.6
Sec. Div. Yield
0.59
Piramal Pharma Resistance and Support
Pivot 137.35
Resistance
First Resistance
139.56
Second Resistance
143.39
Third Resistance
145.6
Support
First Support
133.52
Second Support
131.31
Third Support
127.48
Piramal Pharma Futures & Options
Piramal Pharma Option Chain
View Price, OI, Greeks & More...
30MAR26
138.31
2.91 (2.15%)
28APR26
137.81
3.15 (2.34%)
PPLPHARMA|30MAR26 CE 137.50
3.88
0.66 (20.5%)
PPLPHARMA|30MAR26 PE 140.00
4.26
-2.61 (-37.99%)
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Ratings
Piramal Pharma received an Environment, Social and Governance (ESG) Rating of '68.5' for FY 2024-25 from SES ESG Research Pvt. Ltd. This rating was voluntarily prepared by SES ESG using data available in the public domain, without the company's engagement.
Mar 20 2026 20:03:00
Read More
About Piramal Pharma
NSE : 11571
BSE : 543635
ISIN : INE0DK501011
Piramal Pharma Management
| Name | Position |
|---|---|
| Mrs. Nandini Piramal | Chairperson |
| Mr. Peter DeYoung | Executive Director |
Piramal Pharma Similar Stocks
Krishna Institute of Medical Sciences Ltd
645.10
-12.45 (1.89%)
Dr. Lal Pathlabs Ltd.
1308.20
-17.20 (1.30%)
Pfizer Ltd.
4773.50
49.00 (1.04%)
Sai Life Sciences Ltd.
1000.05
-8.75 (0.87%)
Wockhardt Ltd.
1176.20
-11.10 (0.93%)
Astrazeneca Pharma India Ltd.
8321.00
-49.50 (0.59%)
Acutaas Chemicals Ltd.
2399.80
158.50 (7.07%)
Eris Lifesciences Ltd.
1300.10
13.90 (1.08%)
Natco Pharma Ltd.
959.20
21.15 (2.25%)
Onesource Specialty Pharma Ltd.
1456.40
-9.10 (0.62%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 138.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 2.28. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 59.61 & 2.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 18390.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 240.95 & 134.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
